Sina Tip: Comments section of this article belong to stocks, securities advice only on the relevant units or plates and analysis of personal views, not official news, Sina does not guarantee its authenticity and objectivity, which investors operate your own risk . The accuracy of all information relating to the Unit, please notice, whichever is the Shanghai and Shenzhen Stock Exchange.
Dafu谭伟成investment
Reuters February 24 published studies showed that the largest pharmaceutical company is currently 2.5 billion annual vaccine. If a sudden outbreak of avian influenza, pharmaceutical plants need four years to meet the global demand for vaccines, researchers said that by 2014 annual production capacity is expected to increase to 5.1-14.7 billion. Vaccine pharmaceutical companies will have to race against time in full swing. Abroad, the proliferation of the spread of bird flu, country surrounding the epidemic situation is grim, this avian influenza vaccine for the industrial development brought about by the vast space. An active interest in related industries may wish to listed companies pulo shares (000,739).
The largest domestic companies are amantadine and rimantadine manufacturers of raw materials, raw materials annual production capacity of 380 tons, accounting for about 65% market share, agents reach an annual output of 200,000,000 rimantadine tablets and 10 million bottles of Diamond B amine Koufuye scale. From China's Ministry of Health recommend the use of influenza antiviral drugs to combat the look, the company anti-viral drugs rimantadine and amantadine ranks one of and included in the Ministry of Health announced the Human bird flu clinic program. Yasuhiro pharmaceutical production M2 ion channel blocker rimantadine raw materials and tablets, was listed as the stock of pharmaceuticals to combat avian flu. The current global avian influenza vaccine production and demand enormous contradictions, the company's estate a good prospect.
Trend, the stock Friday by the 60 day moving average of the strong support, maintained a rising channel well, and now shares were down near the channel has stabilized, once the trend has stabilized, a wave of independence is expected to counterattack market, investors can actively concerned.
No comments:
Post a Comment